The Patent Finder

Entos Pharmaceuticals Inc.

Also on record
Records under this name other than the patents Entos Pharmaceuticals Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.

Showing 1 to 2 of 2 · Back to Entos Pharmaceuticals Inc.

PatentTitleStatus Expires Confidence
US 7,851,595Membrane fusion proteins derived from reovirus
Lapsed on the fee record
Ended Dec 14, 2022 · From the USPTO record
Lapsed on the fee recordEnded Dec 14, 2022From the USPTO record
US 8,252,901Membrane fusion proteins derived from reovirus
Term ended
Ended no later than Nov 30, 2021 · From the USPTO record
Term endedEnded no later than Nov 30, 2021From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited